ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Nasdaq: ARWR · CIK 0000879407 · United States
Every official ARROWHEAD PHARMACEUTICALS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ARWR filings
ARROWHEAD PHARMACEUTICALS, INC. documents
- ARROWHEAD PHARMACEUTICALS, INC. 10-K 2026ARWR 10-K 2026: annual report for fiscal 2026
- ARROWHEAD PHARMACEUTICALS, INC. 10-K 2025ARWR 10-K 2025: annual report for fiscal 2025
- ARROWHEAD PHARMACEUTICALS, INC. 10-K 2024ARWR 10-K 2024: annual report for fiscal 2024
- ARROWHEAD PHARMACEUTICALS, INC. 10-K 2023ARWR 10-K 2023: annual report for fiscal 2023
- ARROWHEAD PHARMACEUTICALS, INC. 10-K 2022ARWR 10-K 2022: annual report for fiscal 2022
- ARROWHEAD PHARMACEUTICALS, INC. 10-Q 2026ARWR 10-Q 2026: quarterly report for fiscal 2026
- ARROWHEAD PHARMACEUTICALS, INC. 10-Q 2025ARWR 10-Q 2025: quarterly report for fiscal 2025
- ARROWHEAD PHARMACEUTICALS, INC. 10-Q 2024ARWR 10-Q 2024: quarterly report for fiscal 2024
- ARROWHEAD PHARMACEUTICALS, INC. 10-Q 2023ARWR 10-Q 2023: quarterly report for fiscal 2023
- ARROWHEAD PHARMACEUTICALS, INC. 10-Q 2022ARWR 10-Q 2022: quarterly report for fiscal 2022
- ARROWHEAD PHARMACEUTICALS, INC. 8-K 2026ARWR 8-K 2026: current report for fiscal 2026
- ARROWHEAD PHARMACEUTICALS, INC. 8-K 2025ARWR 8-K 2025: current report for fiscal 2025
- ARROWHEAD PHARMACEUTICALS, INC. 8-K 2024ARWR 8-K 2024: current report for fiscal 2024
- ARROWHEAD PHARMACEUTICALS, INC. 8-K 2023ARWR 8-K 2023: current report for fiscal 2023
- ARROWHEAD PHARMACEUTICALS, INC. 8-K 2022ARWR 8-K 2022: current report for fiscal 2022
- ARROWHEAD PHARMACEUTICALS, INC. DEF 14A 2026ARWR DEF 14A 2026: proxy statement for fiscal 2026
- ARROWHEAD PHARMACEUTICALS, INC. DEF 14A 2025ARWR DEF 14A 2025: proxy statement for fiscal 2025
- ARROWHEAD PHARMACEUTICALS, INC. DEF 14A 2024ARWR DEF 14A 2024: proxy statement for fiscal 2024
- ARROWHEAD PHARMACEUTICALS, INC. DEF 14A 2023ARWR DEF 14A 2023: proxy statement for fiscal 2023
- ARROWHEAD PHARMACEUTICALS, INC. DEF 14A 2022ARWR DEF 14A 2022: proxy statement for fiscal 2022
- ARROWHEAD PHARMACEUTICALS, INC. Form 4 2026ARWR Form 4 2026: insider trading filing for fiscal 2026
- ARROWHEAD PHARMACEUTICALS, INC. Form 4 2025ARWR Form 4 2025: insider trading filing for fiscal 2025
- ARROWHEAD PHARMACEUTICALS, INC. Form 4 2024ARWR Form 4 2024: insider trading filing for fiscal 2024
- ARROWHEAD PHARMACEUTICALS, INC. Form 4 2023ARWR Form 4 2023: insider trading filing for fiscal 2023
- ARROWHEAD PHARMACEUTICALS, INC. Form 4 2022ARWR Form 4 2022: insider trading filing for fiscal 2022
- ARROWHEAD PHARMACEUTICALS, INC. S-1 2026ARWR S-1 2026: registration statement for fiscal 2026
- ARROWHEAD PHARMACEUTICALS, INC. S-1 2025ARWR S-1 2025: registration statement for fiscal 2025
- ARROWHEAD PHARMACEUTICALS, INC. S-1 2024ARWR S-1 2024: registration statement for fiscal 2024
- ARROWHEAD PHARMACEUTICALS, INC. S-1 2023ARWR S-1 2023: registration statement for fiscal 2023
- ARROWHEAD PHARMACEUTICALS, INC. S-1 2022ARWR S-1 2022: registration statement for fiscal 2022
- ARROWHEAD PHARMACEUTICALS, INC. 13F 2026ARWR 13F 2026: institutional holdings for fiscal 2026
- ARROWHEAD PHARMACEUTICALS, INC. 13F 2025ARWR 13F 2025: institutional holdings for fiscal 2025
- ARROWHEAD PHARMACEUTICALS, INC. 13F 2024ARWR 13F 2024: institutional holdings for fiscal 2024
- ARROWHEAD PHARMACEUTICALS, INC. 13F 2023ARWR 13F 2023: institutional holdings for fiscal 2023
- ARROWHEAD PHARMACEUTICALS, INC. 13F 2022ARWR 13F 2022: institutional holdings for fiscal 2022
More companies